{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:48:40Z","timestamp":1789753720030,"version":"4.0.1"},"reference-count":109,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals S.A."}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.1080\/14760584.2020.1853532","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T10:44:45Z","timestamp":1607078685000},"page":"1499-1514","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":18,"title":["A review of rotavirus vaccine use in Asia and the Pacific regions: challenges and future prospects"],"prefix":"10.1080","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1372-3008","authenticated-orcid":false,"given":"Philippe","family":"Buchy","sequence":"first","affiliation":[{"name":"GSK","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7611-4173","authenticated-orcid":false,"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"GSK","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Hao","family":"Zhang","sequence":"additional","affiliation":[{"name":"GSK","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1264-7074","authenticated-orcid":false,"given":"Bernd","family":"Benninghoff","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2220-187X","authenticated-orcid":false,"given":"Christa","family":"Lee","sequence":"additional","affiliation":[{"name":"GSK","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8512-6857","authenticated-orcid":false,"given":"Gyneth Lourdes","family":"Bibera","sequence":"additional","affiliation":[{"name":"GSK","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"key":"e_1_3_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30276-1"},{"key":"e_1_3_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31012-1"},{"key":"e_1_3_10_5_1","volume-title":"Introduction of rotavirus vaccines: information for policy makers, programme managers, and health workers","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Introduction of rotavirus vaccines: information for policy makers, programme managers, and health workers. Geneva: Department of Immunization, Vaccines and Biologicals; 2013. [updated 31 July 2013; cited 13 May 2019]. Available from: http:\/\/www.who.int\/iris\/handle\/10665\/90374"},{"key":"e_1_3_10_6_1","volume-title":"Rotavirus","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Rotavirus. Geneva: World Health Organization; 2018. [updated December 2018; cited 13 May 2009]. Available from: https:\/\/www.who.int\/immunization\/diseases\/rotavirus\/en\/"},{"key":"e_1_3_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(11)70253-5"},{"key":"e_1_3_10_8_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.1960"},{"issue":"88","key":"e_1_3_10_9_1","first-page":"49","article-title":"Rotavirus vaccines. WHO position paper \u2013 january 2013","volume":"5","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Rotavirus vaccines. WHO position paper \u2013 january 2013. Wkly Epidemiol Rec. 2013;5(88):49\u201364.","journal-title":"Wkly Epidemiol Rec"},{"key":"e_1_3_10_10_1","volume-title":"Data visualization platform","author":"International Vaccine Access Center (IVAC)","unstructured":"International Vaccine Access Center (IVAC). Data visualization platform. Baltimore (MD): Johns Hopkins Bloomberg School of Public Health; [cited 2020 Jun 16]. Available from: www.view-hub.org"},{"key":"e_1_3_10_11_1","volume-title":"Global Health Observatory (GHO) data","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Global Health Observatory (GHO) data. Geneva: World Health Organization; 2019 [cited 19 May 2019]. Available from: https:\/\/www.who.int\/gho\/immunization\/rotavirus\/en\/"},{"key":"e_1_3_10_12_1","volume-title":"Global Introduction Status","author":"RotaCouncil","year":"2018","unstructured":"RotaCouncil. Global Introduction Status. Baltimore (MD): John Hopkins Bloomberg School of Public Health; 2018. [updated August 2018; cited 19 May 2019]. Available from: http:\/\/rotacouncil.org\/vaccine-introduction\/global-introduction-status\/"},{"key":"e_1_3_10_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.12.092"},{"key":"e_1_3_10_14_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002298"},{"key":"e_1_3_10_15_1","volume-title":"Regional Office for the Western Pacific","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Regional Office for the Western Pacific. Geneva: World Health Organnization; 2019 [cited 13 May2019].Available from: https:\/\/www.who.int\/about\/regions\/wpro\/en\/"},{"key":"e_1_3_10_16_1","volume-title":"Regional office for South-East Asia","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Regional office for South-East Asia. Geneva: World Health Organization; 2019 [cited 19 May 2019]. Available from: http:\/\/www.searo.who.int\/en\/"},{"key":"e_1_3_10_17_1","volume-title":"World bank country and lending groups","author":"The World Bank","year":"2018","unstructured":"The World Bank. World bank country and lending groups. Washington D.C (USA): The World Bank; 2018. [updated 2018; cited 8 August 2019]. Available from: https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups"},{"key":"e_1_3_10_18_1","unstructured":"United Nations- Department of Economic and Social Affairs. Population dynamics: population by age groups - both sexes.2019 [cited 23 Jul 2020]. Available from: https:\/\/population.un.org\/wpp\/Download\/Standard\/Population\/"},{"key":"e_1_3_10_19_1","volume-title":"Estimated rotavirus deaths for children under 5 years of age: 2013, 215 000","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. Estimated rotavirus deaths for children under 5 years of age: 2013, 215 000. Geneva: World Health Organization; 2013. [cited 19 May 2019]. Available from https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/estimates\/rotavirus\/en\/"},{"key":"e_1_3_10_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001706"},{"key":"e_1_3_10_21_1","unstructured":"World Health Organization. WHO global invasive bacterial vaccine preventable disease and rotavirus surveillance network bulletin. 2016 [cited 1 May 2018]. Available from: https:\/\/us13.campaign-archive.com\/?u=920b793663d2f2d5f22813b38&id=70d8b1b8e1&e=c6286c7b11"},{"key":"e_1_3_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.008"},{"key":"e_1_3_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.05.031"},{"key":"e_1_3_10_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e31829f2cb0"},{"key":"e_1_3_10_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.044"},{"key":"e_1_3_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.02.010"},{"key":"e_1_3_10_27_1","doi-asserted-by":"publisher","DOI":"10.2149\/tmh.2014-22"},{"key":"e_1_3_10_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.07.004"},{"key":"e_1_3_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2015.11.011"},{"key":"e_1_3_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.04.030"},{"issue":"4","key":"e_1_3_10_31_1","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.33321\/cdi.2017.41.48","article-title":"Australian rotavirus surveillance program: annual report, 2016","volume":"41","author":"Roczo-Farkas S","year":"2017","unstructured":"Roczo-Farkas S, Kirkwood CD, Bines JE, et al. Australian rotavirus surveillance program: annual report, 2016. Commun Dis Intell Q Rep. 2017;41(4):E455\u2013E471.","journal-title":"Commun Dis Intell Q Rep"},{"key":"e_1_3_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.03.030"},{"key":"e_1_3_10_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy197"},{"key":"e_1_3_10_34_1","unstructured":"GAVI Alliance. Lao PDR Support for Rotavirus Vaccine. 2018 [cited 13 August 2020]. Available from: https:\/\/www.gavi.org\/sites\/default\/files\/document\/decision-letter-nvs-lao-pdr-2018-%282%29pdf.pdf"},{"key":"e_1_3_10_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.10.078"},{"key":"e_1_3_10_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.10.036"},{"issue":"10","key":"e_1_3_10_37_1","first-page":"e64","article-title":"Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design","volume":"4","author":"Zhen SS","year":"2015","unstructured":"Zhen SS, Li Y, Wang SM, et al. Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design. Emerg Microbes Infect. 2015;4(10):e64.","journal-title":"Emerg Microbes Infect"},{"key":"e_1_3_10_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.07.007"},{"key":"e_1_3_10_39_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-017-0916-7"},{"key":"e_1_3_10_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.11.056"},{"key":"e_1_3_10_41_1","doi-asserted-by":"publisher","DOI":"10.1086\/600395"},{"key":"e_1_3_10_42_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002282"},{"key":"e_1_3_10_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.08.047"},{"key":"e_1_3_10_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-32595-9"},{"key":"e_1_3_10_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000105"},{"key":"e_1_3_10_46_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1754.2010.01953.x"},{"key":"e_1_3_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.07.018"},{"key":"e_1_3_10_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.12.043"},{"key":"e_1_3_10_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.04.058"},{"key":"e_1_3_10_50_1","volume-title":"Highlights of prescribing information: ROTARIX (Rotavirus Vaccine, Live, Oral)","author":"GlaxoSmithKline","year":"2019","unstructured":"GlaxoSmithKline. Highlights of prescribing information: ROTARIX (Rotavirus Vaccine, Live, Oral). North Carolina (USA): GlaxoSmithKline; 2019. [updated March 2019; cited 08 August 2019]. Available from: https:\/\/www.gsksource.com\/pharma\/content\/dam\/GlaxoSmithKline\/US\/en\/Prescribing_Information\/Rotarix\/pdf\/ROTARIX-PI-PIL.PDF"},{"key":"e_1_3_10_51_1","volume-title":"Highlights of prescribing information: RotaTeq (R) (Rotavirus Vaccine, Live, Oral, Pentavalent)","author":"Merck & Co. Inc","year":"2018","unstructured":"Merck & Co. Inc. Highlights of prescribing information: RotaTeq (R) (Rotavirus Vaccine, Live, Oral, Pentavalent). New Jersey: Merck & Co., Inc; 2018. [updated March 2018; cited 08 August 2019]. Available from: https:\/\/www.merck.com\/product\/usa\/pi_circulars\/r\/rotateq\/rotateq_pi.pdf"},{"issue":"15","key":"e_1_3_10_52_1","first-page":"255","article-title":"Risk of intussusception after rotavirus vaccination","volume":"114","author":"Koch J","year":"2017","unstructured":"Koch J, Harder T, von Kries R, et al. Risk of intussusception after rotavirus vaccination. Dtsch Arztebl Int. 2017;114(15):255\u2013262.","journal-title":"Dtsch Arztebl Int"},{"key":"e_1_3_10_53_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000715"},{"key":"e_1_3_10_54_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit520"},{"key":"e_1_3_10_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0929-6646(09)60067-X"},{"key":"e_1_3_10_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.03.036"},{"key":"e_1_3_10_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2009.07.098"},{"key":"e_1_3_10_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.03.030"},{"key":"e_1_3_10_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000362"},{"key":"e_1_3_10_60_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-29515-2"},{"key":"e_1_3_10_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3800"},{"key":"e_1_3_10_62_1","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.2017.58.3.631"},{"key":"e_1_3_10_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.03.038"},{"key":"e_1_3_10_64_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000001644"},{"key":"e_1_3_10_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.04.050"},{"key":"e_1_3_10_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.008"},{"key":"e_1_3_10_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.03.014"},{"key":"e_1_3_10_68_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187446"},{"key":"e_1_3_10_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31012-1"},{"key":"e_1_3_10_70_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00534.x"},{"key":"e_1_3_10_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.05.087"},{"key":"e_1_3_10_72_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1356962"},{"key":"e_1_3_10_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.08.103"},{"key":"e_1_3_10_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.02.047"},{"issue":"1","key":"e_1_3_10_75_1","first-page":"114","article-title":"Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai Children","volume":"41","author":"Chotivitayatarakorn P","year":"2010","unstructured":"Chotivitayatarakorn P, Chotivitayatarakorn P, Poovorawan Y. Cost-effectiveness of rotavirus vaccination as part of the national immunization program for Thai Children. Southeast Asian J Trop Med Public Health. 2010;41(1):114\u2013125.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"e_1_3_10_76_1","doi-asserted-by":"publisher","DOI":"10.7883\/yoken.64.277"},{"key":"e_1_3_10_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.03.037"},{"key":"e_1_3_10_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.10.007"},{"key":"e_1_3_10_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix369"},{"key":"e_1_3_10_80_1","volume-title":"Progress and challenges with achieving universal immunization coverage","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Progress and challenges with achieving universal immunization coverage. Geneva: World Health Organization; 2018. [updated July 2019; cited 19 May 2019]. Available from: https:\/\/www.who.int\/immunization\/monitoring_surveillance\/who-immuniz.pdf"},{"issue":"29","key":"e_1_3_10_81_1","first-page":"135","article-title":"Rotavirus infection: an unrecognised disease in Nepal","volume":"8","author":"Pun SB","year":"2010","unstructured":"Pun SB. Rotavirus infection: an unrecognised disease in Nepal. Kathmandu Univ Med J (KUMJ). 2010;8(29):135\u2013140.","journal-title":"Kathmandu Univ Med J (KUMJ)"},{"key":"e_1_3_10_82_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2016.1252493"},{"key":"e_1_3_10_83_1","doi-asserted-by":"publisher","DOI":"10.1086\/605035"},{"key":"e_1_3_10_84_1","volume-title":"Rotavirus: common, severe, devastating, preventable","author":"RotaCouncil","year":"2016","unstructured":"RotaCouncil. Rotavirus: common, severe, devastating, preventable. Baltimore (MD): John Hopkins Bloomberg School of Public Health; 2016. [updated February 2016; cited 8 August 2019]. Available from: http:\/\/rotacouncil.org\/wp-content\/uploads\/2016\/11\/Rotavirus-Severe-Preventable-White-Paper-Full.pdf"},{"key":"e_1_3_10_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.09.046"},{"key":"e_1_3_10_86_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068482"},{"key":"e_1_3_10_87_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2020.1770035"},{"key":"e_1_3_10_88_1","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000000359"},{"key":"e_1_3_10_89_1","unstructured":"World Health Organization. Global advisory committee on vaccine safety 4\u20135 December 2019. 2020 [cited 17Jun 2020]. Available from: https:\/\/extranet.who.int\/iris\/restricted\/bitstream\/handle\/10665\/330607\/WER9504-eng-fre.pdf?ua=1"},{"key":"e_1_3_10_90_1","volume-title":"Accelerating Rotavirus Vaccines in Asia: ASVAC Session Summary","author":"RotaCouncil","year":"2015","unstructured":"RotaCouncil. Accelerating Rotavirus Vaccines in Asia: ASVAC Session Summary. Baltimore (MD): John Hopkins Bloomberg School of Public Health; 2015. [updated 14 June 2015; cited 8 August 2019]. Available from: http:\/\/rotacouncil.org\/accelerating-rotavirus-vaccines-in-asia-asvac-session-summary\/"},{"key":"e_1_3_10_91_1","unstructured":"World Health Organization \u2013 Regional Office for the Western Pacific. Sixth pacific immunization programme strengthening (pips) workshop. 2011 [cited 30 July 2020]. Available from: https:\/\/iris.wpro.who.int\/bitstream\/handle\/10665.1\/10640\/RS_2010_GE_47_FIJ_eng.pdf"},{"key":"e_1_3_10_92_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1006.030519"},{"key":"e_1_3_10_93_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz117"},{"key":"e_1_3_10_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.05.045"},{"key":"e_1_3_10_95_1","unstructured":"Pan American Health Organization. Overview of the ProVac Initiative. 2017 [cited 17 June 2020]. Available from: https:\/\/www.paho.org\/hq\/index.php?option=com_docman&view=download&category_slug=im-provac-communication-materials-9600&alias=43387-provac-brochure-2017-387&Itemid=270&lang=en"},{"key":"e_1_3_10_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.10.068"},{"key":"e_1_3_10_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.12.056"},{"key":"e_1_3_10_98_1","doi-asserted-by":"publisher","DOI":"10.1080\/20016689.2020.1719588"},{"key":"e_1_3_10_99_1","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.17-0586"},{"key":"e_1_3_10_100_1","volume-title":"Eligibility and transition policy","author":"GAVI Alliance","year":"2019","unstructured":"GAVI Alliance. Eligibility and transition policy. Washington D.C.: GAVI Alliance; 2019. [updated 2019; cited 8 August 2019]. Available from: https:\/\/www.gavi.org\/support\/sustainability\/eligibility\/"},{"key":"e_1_3_10_101_1","volume-title":"Transitioning out of GAVI support","author":"GAVI Alliance","year":"2019","unstructured":"GAVI Alliance. Transitioning out of GAVI support. Washington D.C: GAVI Alliance; 2019. [updated 2019; cited 15 November 2019]. Available from: https:\/\/www.gavi.org\/support\/sustainability\/transition\/"},{"key":"e_1_3_10_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.06.033"},{"key":"e_1_3_10_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2011.10.005"},{"key":"e_1_3_10_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.01.039"},{"key":"e_1_3_10_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2010.02.027"},{"key":"e_1_3_10_106_1","doi-asserted-by":"publisher","DOI":"10.1093\/heapol\/czz027"},{"key":"e_1_3_10_107_1","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000397"},{"key":"e_1_3_10_108_1","volume-title":"Sustaining access to vaccination in India (SAVI)","author":"International Vaccine Access Center (IVAC)","unstructured":"International Vaccine Access Center (IVAC). Sustaining access to vaccination in India (SAVI). Baltimore (MD): John Hopkins Bloomberg School of Public Health; [cited 12 September 2019]. Available from: https:\/\/www.jhsph.edu\/ivac\/projects\/savi\/"},{"key":"e_1_3_10_109_1","unstructured":"Bangkok Post. Rotavirus shots by next year govt says. 2019. [updated 23 May 2019; cited 13 November 2019]. Available from: https:\/\/www.bangkokpost.com\/thailand\/general\/1682700\/rotavirus-shots-by-next-year-govt-says"},{"key":"e_1_3_10_110_1","unstructured":"Pharma Japan. Rotavirus vaccines added to public vaccination programs from Oct. 1 2020: MHLW Panel. 2019 [updated 30 September 2019; cited 14 November 2019]. Available from: https:\/\/pj.jiho.jp\/article\/240734"},{"key":"e_1_3_10_111_1","volume-title":"DPR Korea introduces pentavalent vaccine","author":"GAVI Alliance","year":"2019","unstructured":"GAVI Alliance. DPR Korea introduces pentavalent vaccine. Washington D.C: GAVI Alliance; 2019. [updated 2019; cited 18 August 2019]. Available from: https:\/\/www.gavi.org\/library\/news\/gavi-features\/2012\/dpr-korea-introduces-pentavalent-vaccine\/"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2020.1853532","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T20:02:37Z","timestamp":1770926557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2020.1853532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":109,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,2]]}},"alternative-id":["10.1080\/14760584.2020.1853532"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2020.1853532","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,20]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}